Toggle Main Menu Toggle Search

Open Access padlockePrints

Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemia

Lookup NU author(s): Professor Alan Boddy, Julieann Sludden, Melanie Griffin, Professor Herbie Newell, Professor Stephen O'Brien


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Purpose: To investigate the potential use of accelerator mass spectrometry (AMS) in the study of the clinical pharmacology of imatinib. Experimental Design: Six patients who were receiving imatinib (400 mg/d) as part of their ongoing treatment for chronic myeloid leukemia (CML) received a dose containing a trace quantity (13.6 kBq) of 14C-imatinib. Blood samples were collected from patients before and at various times up to 72 h after administration of the test dose and were processed to provide samples of plasma and peripheral blood lymphocytes (PBL). Samples were analyzed by AMS, with chromatographic separation of parent compound from metabolites. In addition, plasma samples were analyzed by liquid chromatography/mass spectrometry (LCMS). Results: Analysis of the AMS data indicated that imatinib was rapidly absorbed and could be detected in plasma up to 72 h after administration. Imatinib was also detectable in PBL at 24 h after administration of the 14C- labeled dose. Comparison of plasma concentrations determined by AMS with those derived by LCMS analysis gave similar average estimates of area under plasma concentration time curve (26 ± 3 versus 27 ± 11 μg/mL·h), but with some variation within each individual. Conclusions: Using this technique, data were obtained in a small number of patients on the pharmacokinetics of a single dose of imatinib in the context of chronic dosing, which could shed light on possible pharmacologic causes of resistance to imatinib in CML. ©2007 American Association for Cancer Research.

Publication metadata

Author(s): Boddy, A. V., Sludden, J., Griffin, M. J., Garner, C., Kendrick, J., Mistry, P., Dutreix, C., Newell, D. R., O'Brien, S.

Publication type: Article

Publication status: Published

Journal: Clinical Cancer Research

Year: 2007

Volume: 13

Issue: 14

Pages: 4164-4169

Print publication date: 15/07/2007

ISSN (print): 1078-0432

ISSN (electronic): 1557-3265


DOI: 10.1158/1078-0432.CCR-06-2179

PubMed id: 17634544


Altmetrics provided by Altmetric